Dental Equipment Market Worth $10.47 Billion By 2025

The global dental equipment market size is expected to reach USD 10.47 billion by 2025, according to a report published by Grand View Research, Inc. It is anticipated to expand at a lucrative CAGR of 4.5% over the forecast period. Key factors attributed to the growth include increasing demand for dental procedures owing to prevalence of dental disorders and rising awareness and demand for preventive, restorative, and surgical services for dental care.

Moreover, favorable government initiatives regarding dental hygiene is also a significant factor responsible for driving the market. Due to increasing number of initiatives, there is an increase in awareness regarding dental hygiene leading to increasing adoption of dental treatments, which in turn is anticipated to drive the market for dental equipment over the forecast period.

Dental equipment are classified on the basis of product into dental radiology, dental lasers, systems and parts, laboratory machines, hygiene equipment, and others. The systems and parts segment held the leading market share of 39.9% in 2018 and is anticipated to grow at a lucrative pace over the forecast period. The segment is further classified into instrument delivery systems, vacuums and compressors cone beam CT systems, cast machines, furnace and ovens, CAD/CAM, and electrosurgical equipment. The CAD/CAM sub-segment led in 2018 owing to the technological superiority of these equipment over traditional die casting techniques.

North America led with a market share of 29.6% in 2018. Some of the key reasons attributed to the high share include technological advancements, rising demand for dental surgeries, growing geriatric population, and increasing number of dentists and dental clinics. On the other hand, Asia Pacific is expected to expand at the fastest CAGR of 4.9% over the forecast period. Constantly developing healthcare infrastructure and increasing healthcare expenditure coupled with the presence of high unmet medical needs are expected to serve this market as high-impact rendering drivers.

Few significant companies venturing in the market include, Denstply International Inc.; A-Dec Inc.; Planmeca Oy; Sirona Dental Systems Inc.; Patterson Companies Inc.; Straumann; GC Corporation; Carestream Health Inc.; Biolase Inc.; Danaher Corporation; and 3M.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/dental-equipment-market

Further key findings from the report suggest:

Systems and parts product segment led the market in 2018 and is anticipated to grow at a lucrative rate over the forecast period
CAD/CAM sub-segment of systems and parts accounted for the largest market share in terms of revenue in 2018, owing to technological advancements
North America led the dental equipment market in 2018 with a revenue share of USD 1.84 billion owing to the presence of advanced healthcare facilities and strong reimbursement scenarios
Some of the key players operating in the market are, Cook Medical; Smiths Medical; Edwards Life Sciences Corporation; Medtronic Inc.; and Johnson & Johnson.

Molecular Diagnostics Market Worth $18.2 Billion By 2027

The global molecular diagnostics market size is expected to reach USD 18.2 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 9.0% over the forecast period. Increasing prevalence of infectious diseases such as influenza and human papillomavirus is projected to be the key factor the growth of the market.

In the underdeveloped regions of Africa, increasing instances of infections such as tuberculosis and HIV have been witnessed in the last few years. This is projected to drive the demand for accurate and early diagnostic techniques to curb the spread of these infections.

Rapid technological advancements-leading to accurate results, portability, and cost-effectiveness-are expected to be a high impact rendering driver for this market. Companies are upgrading their products by implementing new techniques to gain specific and accurate results. Companies such as Sigma Aldrich Corporation and Qiagen are developing a new range of molecular diagnostic techniques, such as Transcription-Mediated Amplification (TMA) and Loop-Mediated Isothermal Amplification (LAMP), for the diagnosis of tumors.

Key players in the market are adopting various marketing strategies such as collaborations with technologically advanced companies and diagnostic centers. Furthermore, players are focusing on expanding their geographic presence in order to increase their market share.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/molecular-diagnostics-market

Further key findings from the study suggest:

Reagents dominated the market in 2019 and is also projected to be the fastest-growing product segment owing to its high adoption in research and clinical settings. Standard reagents also provide efficient and accurate results
Instruments such as next generation sequencing platforms and PCR are increasingly preferred by diagnostic institutes and central laboratories as these tests deliver reliable and quick results and are suitable for a number of diagnostic procedures
Central laboratories emerged as the leading test location for molecular diagnostics in 2019. This is attributed to the availability of skilled labor and well-established infrastructure
Point-of-care is expected to be the fastest-growing segment over the forecast period owing to increase in demand for bedside testing, accuracy of results, and rise in healthcare awareness
Infectious diseases were the largest revenue generating segment in 2019 as molecular diagnostics offer clinicians with better substitutes to diagnose numerous infectious pathogens, bacteria, and virus in a short time while producing extremely accurate results
The oncology segment is projected to exhibit a CAGR of around 11.3% over the forecast period owing to increasing awareness amongst patients and healthcare professionals regarding available technologies such as molecular testing for cancer diagnosis
On the basis of technology, PCR was the largest revenue generating segment in 2019 owing to factors such as growing applications of multiplex PCR and commercialization of easy-to-use PCR-based molecular diagnostic kits
North America was the largest revenue generating region in 2019, followed by Europe. Key factors attributing to their dominance are high patient awareness levels, sophisticated healthcare infrastructure, growing healthcare expenditure, and high R&D pertaining to drug discovery and development
Some of the major players operating in molecular diagnostics market are F. Hoffmann-La Roche Ltd; Siemens Healthcare GmbH; Bio-Rad Laboratories, Inc.; Novartis AG (Grifols); Danaher Corporation; Alere, Inc.; Sysmex Corporation; bioMérieux SA; Becton, Dickinson and Company; Hologic, Inc. (Gen Probe); Johnson & Johnson Services, Inc.; Bayer AG; Cepheid; Dako; and Qiagen.

Telecom Billing & Revenue Management Market Worth $31.2 Billion By 2027

The global telecom billing and revenue management market size is projected to reach USD 31.2 billion by 2027, expanding at a CAGR of 11.6% during the forecast period, according to a study conducted by Grand View Research, Inc. Telecom billing and revenue management benefits the service providers in exchanging their invoices, billing data, and sharing revenue information with partners, allowing operators to continue the billing accuracy, enhance customer experience by ensuring the end-to-end management of revenue, and disputes and adjustments. It also provides a complete end-to-end solution for supporting key business processes for managing revenue. As a result, the growing importance of identifying profitability and value that customers bring to the enterprise coupled with growing preference for mitigating and identifying the revenue leakages and frauds with automated payment processing solutions and integrated workflows is expected to accelerate the growth of the market over the forecast period.

Growth in the number of subscribers for the telecom services worldwide is one of the key factors driving the growth of the market. As there is a rise in the number of cellular or mobile subscribers, challenges including network congestion and fallout of services are rising. This rise is thereby resulting in structural progress for the development of efficient billing and revenue management software solutions and services. These solutions and services are used by Communication Services Providers (CSPs) to boost their revenue while optimizing telecom networks.

Additionally, telecom billing and revenue management solutions support the telecom service providers in the detection and management of frauds and revenue leakages, thereby resulting in reduced operational costs in the longer run. As a result, telecom companies are investing in telecom billing and revenue management solutions and services to not only help themselves in increasing their revenue growth by optimizing network but also for improving fraud management and reducing operational costs in the long run. This, in turn, is projected to boost the market growth in the near future.

In addition, the telecom billing and revenue management help telecom service providers in creating innovative solutions and services in the market while enhancing the customer experience. Furthermore, with the growth in networks, solutions, and services, telecom operators endure high operational costs. High implementation and operational costs are one of the major challenges likely to deter the progression of the market.

Nevertheless, with the continuous need and requirement to provide improved and high-quality customer experiences and rich communication services, telecom billing and revenue management providers are focusing to further develop advanced solutions and services, which are compatible and at-par to fulfill the dynamic requirement of end-users with improved flexibility, scalability, and functionality. Efficient telecom billing and revenue management solutions help the CSP’s to monetize the usage data and service. It further provides enhanced real-time data analytical capabilities and efficacy to channelize the revenue streams by providing tailored solutions.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/telecom-billing-revenue-management-market

Further key findings from the report suggest:

The cloud segment is expected to witness a CAGR of 15.6% over the forecast period. Owing to low investment cost, scalability, and agility offered by cloud deployment model, the segment is expected to witness significant growth in the coming years
The solutions segment accounted for 67.8% of the market share in 2019. The segment is expected to witness significant growth over the coming years
Asia Pacific is expected to witness a CAGR of more than 15.0% over the forecast period. The growth is accredited to increasing mobile and internet penetration across the region coupled with growth in the telecom industry across the region particularly in the developing economies such as India and China.

Synthetic Aperture Radar Market Worth $4.98 Billion By 2027

The global synthetic aperture radar market size is anticipated to reach USD 4.98 billion by 2027, expanding at a CAGR of 10.7% from 2020 to 2027, according to a study conducted by Grand View Research, Inc. Synthetic aperture radar (SAR) uses a remote sensing technique that generates high-resolution images and can be used for earth observation and surveillance operations. The synthetic aperture of SAR operates at various frequencies and modes, which enable it to take pictures through cloud covers, inclement weathers, and during the day and night. Synthetic aperture radar is compact and light in weight compared to the conventional radars, which is expected to increase the adoption of these devices for space satellite missions and thereby drive the market.

Over the years, SAR has been widely used for military operations, whereas it has also gained prominence in the commercial sector recently. The advanced synthetic aperture technology makes it possible to detect and capture natural disasters, infrastructure damages, archeological artifacts, snow mapping, biomass and vegetation, and oil spillages in oceans, among others. The growing need for tracking and detecting movement, mapping troops, and gathering intelligence data is expected to increase the adoption of these systems in the military operations. Furthermore, synthetic aperture radars can be integrated with unmanned aerial vehicles (UAV’s) and rising usage of UAV for tactical and surveillance purposes is expected to bolster the demand for SAR systems in the market.

The data retrieved from synthetic aperture radar involves using several pre-processing steps and requires a separate software from the service provider to process the data. It may include steps like de-bursting, radiometric calibration, terrain correction, applying the orbit file, and speckle filtering depending on the type of analysis. This tedious process to work with the SAR data is expected to limit market growth. However, the processed images and retrieved data provide a detailed and clear picture of the mapped objects, which is anticipated to drive the market over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/synthetic-aperture-radar-market

Further key findings from the report suggest:

The growing need for public safety, natural resource exploration, and environmental monitoring has propelled investment from government and independent organizations in the synthetic aperture radar systems industry, thus driving the commercial application segment
Asia Pacific is anticipated to expand at the highest CAGR of 14.1% over the forecast period owing to an increase in spending on military missions. The Asia Pacific region is expected to launch satellites in the future, thereby resulting in market growth. For example, the National Aeronautics and Space Administration (NASA) and The Indian Space Research Organization (ISRO) have projected the launch of a dual-frequency synthetic aperture radar NISAR in 2022
Key market players operating in the market are focused on forming partnerships with government and other organizations to accommodate important projects and gain competitive advantage. For instance, in June 2019, ICEYE and Asia Pacific Satellite, Inc. entered a strategic alliance to extend ICEYE’s SAR data purchase in South Korea.

Livestock Farm Equipment Market Size Worth $19.3 Billion By 2027

The global livestock farm equipment market size is expected to reach USD 19.3 billion by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 3.4% over the forecast period. Aggressive investments being made by farm owners to automate dairy and poultry farms are expected to drive the market over the forecast period. Increasing spending on agricultural equipment across the globe also bodes well for market growth. Market players are expected to introduce innovative livestock farm equipment based on the latest technologies, such as IoT and artificial intelligence, thereby contributing to market growth.

Domesticated animal farming is gaining traction in line with the growing population and the changing food habits of individuals. The growing consumption of meat among individuals is particularly driving domesticated animal farming and hence the demand for the tools. At the same time, the increasing consumption of milk, which is encouraging cattle farming, and the rising consumption of eggs, which is encouraging poultry farming, also bodes well for the growth of the market over the forecast period. The demand for tools used in domesticated animal farming is growing as the owners are increasingly opting for such tools to increase the yield and augment revenues and to protect their domesticated animals from diseases by maintaining cleanliness and better hygiene.

The equipment can potentially reduce the costs associated with feeding, cleaning, and monitoring the animals. The owners opt for different equipment depending upon the type of domesticated animals they are farming. For instance, electric cages are used for poultry animals, such as hens, and ducks. Electric cages can ensure proper shelter for poultry animals while reducing the space occupied. The growing preference for electric cages for poultry farming is expected to drive the growth of the market over the forecast period. The owners are also opting for dedicated tools for feeding and monitoring their domesticated animals.

However, the high costs associated with the tools are anticipated to challenge market growth as the owners would deliberate before investing in such equipment. The costs associated with regular maintenance are also expected to restrain the market growth. The outbreak of the COVID-19 pandemic is equally expected to impede market growth in the short term as lockdowns in various parts of the world have disrupted the supply chains and have hampered the equipment production. Nevertheless, the demand for the tools is poised for stable growth in the long term as more and more farm owners opt for automation to overcome the looming workforce shortage.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/livestock-farm-equipment-market

Further key findings from the study suggest:

The feed equipment segment is projected to witness significant growth over the forecast period as farm owners look for efficient means to feed the domesticated animals
The housing equipment is expected to account for a substantial share of the market over the forecast period as housing or shelters continue being farm owners’ essential requirement to accommodate domesticated animals
The poultry farm segment is expected to register the highest CAGR and control a considerable share of the market over the forecast period in line with the rising consumption of eggs and poultry meat across the globe
Asia Pacific held the largest market share of more than 30.0% in 2019 and is expected to continue dominating the market over the forecast period as the region is home to significant market players
Market incumbents are continuously improvising their product portfolio and catering to all the requirements associated with domesticated animal farming. The market is highly fragmented due to the presence of regional players.

Metal 3D Printing Market Worth $14.56 Billion By 2027

The global metal 3D printing market is estimated to reach USD 14.56 billion by 2027, according to the new report by Grand View Research, Inc. The market is expected to register a CAGR of 19.2% from 2020 to 2027. Metal 3D printing is also referred to as Additive Manufacturing (AM) as it involves the successive addition of layers of materials in various 2D shapes using an additive process. These layered 2D shapes are built upon one another to form a three-dimensional object. The process is different from the subtractive method of production, which begins with a block of metal and the unnecessary metal is ground out to obtain the desired object.

The metal 3D printing industry is estimated to exhibit significant growth throughout the forecast period owing to a combination of numerous factors such as growing demand for rapid prototyping, which allows the manufacturers to design and develop better products and systems. Additionally, the ease of manufacturing and added benefits offered by the 3D printing technology are the major factors behind the greater adoption of the technology across various industry verticals.

Metal 3D printing is widely adopted in the industrial sector owing to the growing need for enhanced product manufacturing and a shorter time to market. The automotive vertical happens to be the most significant adopter of the metal 3D printing technology and eventually leading to the largest market share of metal 3D printers for industrial applications over the forecast period. Additive manufacturing is anticipated to evolve over the forecast period.

The market is subject to witness a considerable economical appearance rather than being just a labor-intensive industrial manufacturing technique. Particularly in developing economies, such as Brazil, South Africa, and India, machining shops have managed to adopt alternative business models by installing 3D printers and offer related services, such as 3D printing materials, filaments, 3D modeling, and 3D printer software.

The metal 3D printing technology happens to be capital-intensive technology. At the same time, manufacturers are holding to their misconceptions about prototyping rather than realizing the advantages associated with metal 3D printing. Moreover, the market lacks the standard process controls and a skilled workforce required for metal 3D printing. These are some of the factors that are expected to restrain market growth. However, government initiatives aimed at increasing awareness and promoting the benefits of adopting metal 3D printers are expected to help in countering the market restraints.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/metal-3d-printing-market

Further key findings from the report suggest:

North America accounted for the largest market share in 2019 owing to the early adoption of the technology s
The U.S. being the highest revenue generating country in 2019 in the North America regional market, the region is predicted to exhibit steady growth over the forecast period
Increasing adoption of metal 3D printers in the healthcare, automotive, and consumer electronics verticals is likely to drive the market growth significantly
The Asia Pacific regional market, which is emerging as a manufacturing hub for several industry verticals, is forecast to grow significantly in future as the continued urbanization triggers the need for infrastructure and prompts the automotive, consumer electronics, aerospace and defense, and healthcare verticals to adopt metal 3D printing, particularly in countries, including China, Japan, and South Korea.

Medical Writing Market Worth $7.7 Billion By 2027

The global medical writing market size is expected to reach USD 7.7 billion by 2027, expanding at a CAGR of 10.9% during the forecast period, based on a new report by Grand View Research, Inc. Market growth can be attributed to increasing R&D investments by pharmaceutical companies, rise in contract research organization (CRO) outsourcing, partnerships & collaborations between market players, surge in the number of clinical trials, and updates in medical device regulations.

The European MEDDEV 2.7/1 Rev.4 guidance on Clinical Evaluation Reports (CER) was published in 2016. As per a recent article published in 2018, regulations, such as European Medical Devices Regulation (MDR 2017/745) and In-Vitro Diagnostics Regulation (IVDR 2017/746) followed in May 2017, and key changes relevant to writers in the field of medicine include increased need for relevant data from clinical studies and requirement of experienced authors. Such stringent regulations are expected to positively impact the medical writing market growth.

Drug development is a billion dollar industry with complex processes of obtaining product approvals. A well-documented, well-communicated, and well-developed research is needed to gain product approval, which increases the demand for experienced writers in the field of medicine. In addition, social media has become a crucial part of marketing and communication strategies of many organizations, including healthcare providers. Social networking is now being used in order to engage with patients as part of digital marketing, thereby creating high demand for writing services in the field of medicine.

Strategic alliances between large pharma companies and CROs have become an ongoing trend. Around 20 major partnerships have been finalized in the last five years. For instance, in October 2016, Quintiles and IMS Health underwent the biggest merger in the CRO industry and reestablished the weightage of both the companies. The merger helped Quintiles to use IMS’ internal database in order to design targeted and complex clinical trials.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/medical-writing-market

Further key findings from the study suggest:

By type, the clinical writing segment dominated the market 2019 due to increase in clinical trials. The regulatory writing segment is expected to witness the fastest growth over the forecast period owing to requirement of submission of regulatory documents to the authorities
On the basis of application, medical journalism dominated the market in 2019 and is expected to maintain its lead over the forecast period. Medico marketing is projected to witness the fastest growth over the forecast period
Medical writing has become essential in the field of education as specialized knowledge and skill is required to write well-structured and lucid scientific documents, thus driving the medical education application segment
Based on the end use, the CROs & others accounted for the largest market share in 2019 and is expected to exhibit the fastest CAGR over the forecast period
In 2019, North America dominated the global medical writing market due to increasing number of drug trials and approval of new drugs
Asia Pacific is expected to expand at the fastest CAGR over the forecast period owing to availability of cheap labor, abundance of resources, and presence of English writers
Some of the key players operating in the market are IQVIA; Parexel International Corp.; Trilogy Writing & Consulting GmBH; Covance, Inc.; OMICS International; and Freyr e, Inc.; OMICS International; and Freyr

Cannabis Extract Market Worth $28.5 Billion By 2027

The global cannabis extract market size is expected to be valued at USD 28.5 billion by 2027, according to a new report published by Grand View Research, Inc. It is projected to expand at a CAGR of 16.6% over the forecast period. Growing legalization of cannabis in various countries, preference for cannabis oil and tinctures, and adoption of medical marijuana for treating chronic diseases like arthritis, anxiety, and Alzheimer’s are the major factors propelling the growth.

Cannabis extracts have gained wide recognition in recent years and are expected to provide impetus to cannabis market growth. Based on product type, cannabis extracts are classified into oils and tinctures. The oils segment is expected to dominate the market in 2019 with a revenue of USD 4.8 billion and is anticipated to witness the fastest CAGR of 17.5%, over the forecast period.

Based on extract type, the market is segmented into full spectrum cannabis extracts and cannabis isolates. The full spectrum cannabis extracts dominated the market in 2019, with a revenue of USD 4.3 billion, owing to the added advantage of the entourage effect. Various manufacturers prefer full spectrum cannabis products owing to their advantages over the isolates. Thus, the segment is expected to remain dominant over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/cannabis-extract-market

Further key findings from the report suggest:

In 2019, oils held the largest revenue share of 66.5% owing to ease of availability and low price of the product
The full spectrum segment was valued at USD 4.3 billion in 2019, owing to its entourage effect-a synergistic relationship between cannabinoids and terpenes that exhibits an increase in the healing properties of each cannabinoid
Marijuana isolates is anticipated to emerge as the second largest type segment over the forecast period, owing to several advantages that have increased its adoption. For instance, the purest form of isolates, such as CBD oil, have no psychoactive effects as they have no THC content
In 2019, North America accounted for the largest share in the global cannabis concentrates market. This can be attributed to high utilization owing to government approvals
Key players operating in the cannabis extract market include Canopy Growth Corporation; Aphria Inc.; Aurora Cannabis; Maricann Inc.; Tilray; Organigram Holdings Inc.; Tikun Olam, Ltd.; and The Cronos Group

Europe Hyaluronic Acid Based Dermal Fillers Market Worth $1.4 Billion By 2026

The Europe hyaluronic acid based dermal fillers market size is expected to reach USD 1.4 billion by 2026, according to a new report by Grand View Research Inc., exhibiting a CAGR of 7.6% over the forecast period. Rapidly aging population, large number of cosmetic surgeries performed, and technological advancements are among key factors driving the market. Growing demand to enhance one’s aesthetic appeal is resulting in high number of cosmetic surgeries being performed. This can also be attributed to the availability of noninvasive surgical alternatives and rising awareness among consumers. According to the International Society of Aesthetic Plastic Surgery (ISAPS), in 2017, hyaluronic acid-based dermal filler procedures were among the three most preferred noninvasive aesthetic surgeries.

Minimal adverse effects, lesser pain, shorter recovery time, and fewer postsurgical complications are some of the factors driving preference for minimally invasive surgeries. The European market is dominated by well-known brands such as Juvederm, Restylane, and Belotero. In addition, France has several native brands with different patented technologies, thereby contributing to regional market growth. Stylage, Cytosial, Hyaluronica, and Surface Volume are some of the local brands available in the market.

Increasing demand for aesthetic procedures majorly in Italy and Spain is creating a great opportunity for market expansion. According to the ISAPS, about 952,830 aesthetic surgeries were performed in 2016, of which 650,995 were noninvasive procedures such as Botox and dermal fillers.

Various strategic initiatives such as product launch, approvals, and mergers and acquisitions propel the market. For instance, in January 2017, Allergan plc launched Juvederm VOLITE, a new hyaluronic acid dermal filler with its unique patented VYCROSS technology, which lasts for up to nine months. In another instance, in September 2018, Allergan acquired Bonti, Inc. to expand its product portfolio with Bonti’s pipeline products such as (BoNT/E) botulinum neurotoxin serotype E in phase II, EB-001T (therapeutic), and EB-001A (aesthetic).

Click the link below:
https://www.grandviewresearch.com/industry-analysis/europe-hyaluronic-acid-based-dermal-fillers-market

Further key findings from the study suggest:

Increase in per capita income in countries such as Germany, Italy, France, and Spain is a key factor driving the adoption of dermal fillers. Rapid advancements in dermal filler technology have resulted in better results in lesser time and at lower costs
In 2018, single-phase products dominated the market owing to technological advancements, wide range of applications, and rise in applications of implantable devices
By application, the wrinkle removal segment is anticipated to grow at the fastest rate during the forecast period. Hyaluronic acid dermal fillers are gaining popularity in varied antiaging treatments as they help save time. A general hyaluronic acid anti-wrinkle treatment procedure takes less than an hour and the average cost is approximately USD 600
Italy dominated the regional market in 2018 owing to technological advancements in the region and introduction of new products by prominent manufacturers
Some of the key players in this industry are Allergan; Galderma Laboratories; Merz Pharma; Genzyme Corporation; Medicis Pharmaceutical; Inamed Corporation; Anika Therapeutics, Inc.; Laboratoires VIVACY; Bioxis Pharmaceuticals; and Bohus Biotech AB.

Ambulatory Surgery Center Market Size Worth $120.8 Billion By 2026

The global ambulatory surgery centers market size is expected to reach USD 120.8 billion by 2026, based on a new report by Grand View Research, Inc., exhibiting a 6.1% CAGR during the forecast period. Increase in incidence of chronic diseases and rise in geriatric population have furthered the demand for ambulatory surgery centers. Furthermore, advancements in surgeries, such as endoscopy and laparoscopy, are expected to propel ASC market growth.

The number of patient admissions is slowly decreasing owing to increasing outpatient visits. This is primarily due to high hospitalization cost and adoption of technologically advanced techniques in outpatient centers, making treatment fast and cost-effective. Advanced surgical methods allow tests and procedures to be performed without hospital admission. According to the American Hospital Association, the total number of outpatient admissions increased from 624 million in 2008 to 675 million in 2012. The number of inpatient admissions decreased from 35.76 million in 2008 to 34.40 million in 2012.

In May 2016, some new codes were added to the coverage for outpatient services in U.S., such as that for gynecology, adenoidectomy, and tonsillectomy. Hence, supportive reimbursement scenario is anticipated to boost market growth.

North America held the dominant share in 2018, driven primarily by U.S. Leading market players in the country are acquiring ambulatory services to provide technologically advanced surgeries and treatments, further propelling demand for ambulatory and primary care services. Asia Pacific is likely to emerge as a strong contender in the global scenario. Some of the prominent players in this region are Surgery Center of Melbourne, Nova Medical Centers, Kaiser Permanente, The Indian Association of Day Surgery, Memorial Sloan Kettering, M D Anderson Cancer Center, and The Mumbai Surgical Society.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/ambulatory-surgery-center-asc-market

Further key findings from the study suggest:

In 2018, gastroenterology accounted for the largest share in the market by application. This can be attributed to surge in visits to ambulatory care centers for treatment of gastrointestinal diseases. It is one of the most common surgical specialties in single- or multi-specialty ASCs
Plastic surgery is anticipated to observe the fastest growth in the coming years due to rise in disposable income and growing preference for private care facilities in comparison with hospital surgery centers for plastic surgery. Time and cost advantages, as well as expertise offered by these ambulatory centers, are anticipated to boost demand for plastic surgeries in these settings
North America dominated the market in 2018 thanks to increased government funding focused on transforming primary care services and rise in coverage for outpatient services
Asia Pacific is expected to witness lucrative growth in the coming years owing to presence of developing economies, increasing awareness about ASCs, and investments by international players
Key players in the market include Envision Healthcare Corporation; Terveystalo; Tenet Healthcare Corporation; MEDNAX Services, Inc.; TeamHealth, Quorum Health Corporation; UnitedHealth Group; Surgery Partners; Community Health Systems, Inc.; and Healthway Medical Group.